Base Genomics is a new start-up that aims to have a major impact on personalised medicine. We are developing TAPS, a breakthrough technology from the University of Oxford that makes epigenetic analysis of DNA methylation more sensitive, accurate and cheaper than ever before. We aim to transform healthcare by enabling early and precise detection of cancer. Long-term, we expect TAPS to become central to a host of major new healthcare and research applications.
*We are hiring*
We are looking for talented chemists, enzymologists, protein engineers, NGS specialists, bioinformaticians and software developers at all levels. Check out the available roles at basegenomics.com/join-us
*We are hiring*
We are looking for talented chemists, enzymologists, protein engineers, NGS specialists, bioinformaticians and software developers at all levels. Check out the available roles at basegenomics.com/join-us
Location: United Kingdom, England, Oxford
Employees: 11-50
Total raised: $11M
Founded date: 2019
Investors 1
| Date | Name | Website |
| - | Oxford Sci... | oxfordscie... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 03.06.2020 | Seed | $11M | - |
Mentions in press and media 1
| Date | Title | Description |
| 03.06.2020 | Base Genomics Raises $11M in Seed Funding | Base Genomics, an Oxford, England, UK-based epigenetics company, closed a seed funding round of $11m USD (£9m GBP). The round was led by Oxford Sciences Innovation with participation from investors with industry expertise in genomics and on... |